EBITDA for Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's current EBITDA (TTM) is $2.01B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$2.01B
YoY change
+11.1%
5Y CAGR
-9.1%
Peak year (2021)
$3.68B
Cumulative EBITDA
$39.33B
EBITDA history chart for Labcorp Holdings (LH) from 1988 to 2025
EBITDA history table for Labcorp Holdings (LH) from 1988 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $2.01B | +11.1% | ||
| 2024 | $1.81B | +34.2% | ||
| 2023 | $1.35B | -31.0% | ||
| 2022 | $1.95B | -46.8% | ||
| 2021 | $3.68B | +13.1% | ||
| 2020 | $3.25B | +53.6% | ||
| 2019 | $2.12B | +2.5% | ||
| 2018 | $2.06B | +11.9% | ||
| 2017 | $1.85B | +2.0% | ||
| 2016 | $1.81B | +14.8% | ||
| 2015 | $1.58B | +34.1% | ||
| 2014 | $1.18B | -5.1% | ||
| 2013 | $1.24B | -1.7% | ||
| 2012 | $1.26B | +6.7% | ||
| 2011 | $1.18B | -0.7% | ||
| 2010 | $1.19B | +4.2% | ||
| 2009 | $1.14B | +10.1% | ||
| 2008 | $1.04B | +4.6% | ||
| 2007 | $990.40M | +16.1% | ||
| 2006 | $853.10M | +8.7% | ||
| 2005 | $784.80M | -0.7% | ||
| 2004 | $790.20M | +18.2% | ||
| 2003 | $668.40M | +20.6% | ||
| 2002 | $554.30M | +17.5% | ||
| 2001 | $471.60M | +38.8% | ||
| 2000 | $339.70M | +45.0% | ||
| 1999 | $234.20M | +10.6% | ||
| 1998 | $211.80M | +1110.3% | ||
| 1997 | $17.50M | -90.6% | ||
| 1996 | $186.70M | +33.7% | ||
| 1995 | $139.60M | -9.5% | ||
| 1994 | $154.30M | -29.1% | ||
| 1993 | $217.70M | -4.1% | ||
| 1992 | $227.00M | +16.1% | ||
| 1991 | $195.50M | +23.1% | ||
| 1990 | $158.80M | +25.9% | ||
| 1989 | $126.10M | -59.8% | ||
| 1988 | $313.90M | — |
EBITDA values are taken from Labcorp Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Labcorp Holdings (LH) EBITDA is $2.01B – grew 11.1% year-over-year.
Labcorp Holdings EBITDA has grown for 2 consecutive years, with a -9.1% compound annual growth rate over 2020–2025 (5 years).
Labcorp Holdings EBITDA plunged from $3.68B in 2021 to $2.01B in 2025, a 45.3% drawdown.
$3.68B stands as the all-time-high annual EBITDA, posted in 2021, against a low of $17.50M during 1997.
Within Healthcare, Labcorp Holdings (LH) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Labcorp Holdings EBITDA by Year
Labcorp Holdings EBITDA 2025: $2.01B
Labcorp Holdings EBITDA in 2025 was $2.01B, grew 11.1% from 2024.
Labcorp Holdings EBITDA 2024: $1.81B
Labcorp Holdings EBITDA in 2024 was $1.81B, surged 34.2% from 2023.
Labcorp Holdings EBITDA 2023: $1.35B
Labcorp Holdings EBITDA in 2023 was $1.35B, plunged 31.0% below 2022.
Labcorp Holdings EBITDA 2022: $1.95B
Labcorp Holdings EBITDA in 2022 was $1.95B, plunged 46.8% below 2021.
Labcorp Holdings EBITDA 2021: $3.68B
Labcorp Holdings EBITDA in 2021 was $3.68B.
See more financial history for Labcorp Holdings (LH).
Sector peers — EBITDA
Companies in the same sector as Labcorp Holdings, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Labcorp Holdings's EBITDA?
- Latest reported EBITDA for Labcorp Holdings (LH) is $2.01B (period ending December 31, 2025).
How has Labcorp Holdings EBITDA changed year-over-year?
- Labcorp Holdings (LH) EBITDA changed +11.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings EBITDA?
- Labcorp Holdings (LH) EBITDA compound annual growth rate is -9.1% over the most recent 5 years available.
When did Labcorp Holdings EBITDA hit its highest annual value?
- Labcorp Holdings EBITDA reached its highest annual value of $3.68B in 2021.
What was Labcorp Holdings EBITDA in 2024?
- Labcorp Holdings (LH) EBITDA in 2024 was $1.81B.
What was Labcorp Holdings EBITDA in 2025?
- Labcorp Holdings (LH) EBITDA in 2025 was $2.01B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.